-+ 0.00%
-+ 0.00%
-+ 0.00%

Richter agrees to acquire Mayne Pharma for AUD 6.40 per share

PUBT·11/16/2026 22:22:42
Listen to the news
Richter agrees to acquire Mayne Pharma for AUD 6.40 per share
  • Richter agreed to acquire all shares in Mayne Pharma for AUD 6.4 apiece, valuing its equity at approximately AUD 604 million.
  • The offer represents a 99.4% premium to Mayne Pharma’s November 16, 2026, closing price; internal cash resources will fund the acquisition.
  • The acquisition would expand the buyer’s US footprint in women’s health and dermatology.
  • Completion requires regulatory, shareholder and court approvals, alongside completion of Mayne Pharma’s International business sale to Evaris Pharma.
  • The shareholder vote is expected in late January 2027, with implementation targeted for mid-to-late March 2027.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gedeon Richter plc published the original content used to generate this news brief on November 16, 2026, and is solely responsible for the information contained therein.